STAT3 and breast cancer: In this study, we identified 3-(2,4-dichloro-phenoxymethyl)-5-trichloromethyl-[1,2,4]oxadiazole (ODZ10117) as a novel STAT3 inhibitor and examined the anticancer activity of ODZ10117 in models of breast cancer.